Kevin Caliendo
Stock Analyst at UBS
(4.17)
# 459
Out of 5,026 analysts
190
Total ratings
68.48%
Success rate
8.37%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
LH Labcorp Holdings | Maintains: Buy | $305 → $325 | $285.99 | +13.64% | 6 | Oct 17, 2025 | |
ALGN Align Technology | Maintains: Neutral | $160 → $155 | $129.82 | +19.40% | 19 | Oct 16, 2025 | |
SOLV Solventum | Initiates: Neutral | $77 | $71.72 | +7.37% | 1 | Oct 1, 2025 | |
PINC Premier | Maintains: Neutral | $26 → $28 | $27.89 | +1.29% | 3 | Sep 25, 2025 | |
MCK McKesson | Maintains: Buy | $820 → $860 | $781.81 | +10.00% | 15 | Sep 24, 2025 | |
CVS CVS Health | Upgrades: Buy | $67 → $79 | $81.76 | -3.38% | 9 | Aug 18, 2025 | |
OMI Owens & Minor | Maintains: Buy | $13 → $7 | $4.80 | +45.83% | 6 | Aug 13, 2025 | |
GDRX GoodRx Holdings | Maintains: Neutral | $5.25 → $4.25 | $3.84 | +10.68% | 6 | Aug 11, 2025 | |
XRAY DENTSPLY SIRONA | Maintains: Buy | $25 → $24 | $12.41 | +93.39% | 11 | Aug 8, 2025 | |
LFST LifeStance Health Group | Maintains: Buy | $8.5 → $9 | $5.04 | +78.57% | 5 | Aug 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $70 | $62.83 | +11.41% | 6 | Aug 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $18 → $22 | $19.73 | +11.51% | 4 | Jul 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $260 → $180 | $189.28 | -4.90% | 4 | Jul 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $175 → $180 | $189.20 | -4.86% | 15 | Jul 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $385 | $356.00 | +8.15% | 12 | Jun 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $10 | $19.00 | -47.35% | 1 | May 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $7.64 | +96.34% | 3 | May 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $5.58 | +61.29% | 3 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $17 | $16.99 | +0.06% | 7 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $170 | $153.20 | +10.97% | 17 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $298 → $335 | $321.12 | +4.32% | 2 | Apr 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $293.64 | +32.82% | 11 | Feb 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $271.93 | -8.06% | 6 | Oct 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $35.67 | +121.51% | 2 | Dec 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $348.00 | +65.23% | 1 | Jul 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $193.26 | -6.86% | 7 | Jul 21, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $8.74 | +724.27% | 4 | Mar 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $19.48 | -43.52% | 4 | May 4, 2021 |
Labcorp Holdings
Oct 17, 2025
Maintains: Buy
Price Target: $305 → $325
Current: $285.99
Upside: +13.64%
Align Technology
Oct 16, 2025
Maintains: Neutral
Price Target: $160 → $155
Current: $129.82
Upside: +19.40%
Solventum
Oct 1, 2025
Initiates: Neutral
Price Target: $77
Current: $71.72
Upside: +7.37%
Premier
Sep 25, 2025
Maintains: Neutral
Price Target: $26 → $28
Current: $27.89
Upside: +1.29%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $820 → $860
Current: $781.81
Upside: +10.00%
CVS Health
Aug 18, 2025
Upgrades: Buy
Price Target: $67 → $79
Current: $81.76
Upside: -3.38%
Owens & Minor
Aug 13, 2025
Maintains: Buy
Price Target: $13 → $7
Current: $4.80
Upside: +45.83%
GoodRx Holdings
Aug 11, 2025
Maintains: Neutral
Price Target: $5.25 → $4.25
Current: $3.84
Upside: +10.68%
DENTSPLY SIRONA
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $24
Current: $12.41
Upside: +93.39%
LifeStance Health Group
Aug 8, 2025
Maintains: Buy
Price Target: $8.5 → $9
Current: $5.04
Upside: +78.57%
Aug 6, 2025
Maintains: Neutral
Price Target: $75 → $70
Current: $62.83
Upside: +11.41%
Jul 29, 2025
Maintains: Neutral
Price Target: $18 → $22
Current: $19.73
Upside: +11.51%
Jul 25, 2025
Maintains: Neutral
Price Target: $260 → $180
Current: $189.28
Upside: -4.90%
Jul 23, 2025
Maintains: Neutral
Price Target: $175 → $180
Current: $189.20
Upside: -4.86%
Jun 25, 2025
Maintains: Buy
Price Target: $400 → $385
Current: $356.00
Upside: +8.15%
May 15, 2025
Maintains: Neutral
Price Target: $16 → $10
Current: $19.00
Upside: -47.35%
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $7.64
Upside: +96.34%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $5.58
Upside: +61.29%
May 2, 2025
Maintains: Neutral
Price Target: $16 → $17
Current: $16.99
Upside: +0.06%
May 2, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $153.20
Upside: +10.97%
Apr 29, 2025
Maintains: Buy
Price Target: $298 → $335
Current: $321.12
Upside: +4.32%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $293.64
Upside: +32.82%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $271.93
Upside: -8.06%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $35.67
Upside: +121.51%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $348.00
Upside: +65.23%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $193.26
Upside: -6.86%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $8.74
Upside: +724.27%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $19.48
Upside: -43.52%